Features
The Environmental Impact of Fluorinated Gas in Retina Surgery
Reducing reliance on fluorinated gases could make retina care more environmentally sustainable.
By Scott M. McClintic, MD, Jacob D. Grodsky, MD, Geoffrey G. Emerson, MD, PhD, FASRS
Best Practices for Clinical Research Site Collaboration
How to avoid an FDA warning letter.
By Thomas A. Ciulla, MD, MBA
Investigational TKIs for Retinal Exudative Diseases
Vorolanib, axitinib, and migaldendranib may offer sustained and targeted therapy for nAMD and DME.
By Priya Vakharia, MD
Placing Argentina on the Clinical Trials Map
Improved research facilities and collaborative networks are establishing the country as a reliable partner for global ophthalmology studies.
By Patricio G. Schlottmann, MD
Web Exclusives
Practice Management for Photobiomodulation of the Retina
Coding, billing, and reimbursement for a novel treatment for dry AMD.
By Kevin J. Corcoran, COE, FNAO
Departments
Thankful
Upfront: This issue features articles on clinical trials and practice management.
By Diana V. Do, MD
What to Look for in a Retina Fellowship
Early Career Perspectives in Retina: Not all programs are the same—here’s how to find the one that fits your goals and personality.
By Jonathan B. Lin, MD, PhD
Documentation Errors, Compliance Consequences
Coding: By aligning documentation, workflows, and staff training, retina practices can minimize denials, reduce audit risk, and maintain a smooth operation.
By Elizabeth Cifers, MBA, MSW, CHC, CPC
Clinical Trial Update November/December 2025
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.